USD
+$0.00
(+0.00%
)At Close (As of Oct 16, 2025)
$28.47M
Market Cap
-
P/E Ratio
-1.19
EPS
$22.38
52 Week High
$3.90
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $7.6M |
Total Revenue | $16M |
Cost Of Revenue | $8.4M |
Costof Goods And Services Sold | $8.4M |
Operating Income | -$4.2M |
Selling General And Administrative | $12M |
Research And Development | $2.3M |
Operating Expenses | $12M |
Investment Income Net | - |
Net Interest Income | -$74K |
Interest Income | - |
Interest Expense | $74K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.5M |
Income Before Tax | -$4.3M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$4.3M |
Comprehensive Income Net Of Tax | - |
Ebit | -$4.2M |
Ebitda | -$2.7M |
Net Income | -$4.3M |
Field | Value (USD) |
---|---|
Total Assets | $17M |
Total Current Assets | $3.5M |
Cash And Cash Equivalents At Carrying Value | $1.4M |
Cash And Short Term Investments | $1.4M |
Inventory | $724K |
Current Net Receivables | $799K |
Total Non Current Assets | $14M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $12M |
Intangible Assets Excluding Goodwill | $12M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $539K |
Other Non Current Assets | - |
Total Liabilities | $4.9M |
Total Current Liabilities | $4.3M |
Current Accounts Payable | $618K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $622K |
Total Non Current Liabilities | $631K |
Capital Lease Obligations | $879K |
Long Term Debt | $77K |
Current Long Term Debt | $297K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.3M |
Other Current Liabilities | $2.6M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $12M |
Treasury Stock | - |
Retained Earnings | -$102M |
Common Stock | $15K |
Common Stock Shares Outstanding | $1.5M |
Field | Value (USD) |
---|---|
Gross Profit | $7.6M |
Total Revenue | $16M |
Cost Of Revenue | $8.4M |
Costof Goods And Services Sold | $8.4M |
Operating Income | -$4.2M |
Selling General And Administrative | $12M |
Research And Development | $2.3M |
Operating Expenses | $12M |
Investment Income Net | - |
Net Interest Income | -$74K |
Interest Income | - |
Interest Expense | $74K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.5M |
Income Before Tax | -$4.3M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$4.3M |
Comprehensive Income Net Of Tax | - |
Ebit | -$4.2M |
Ebitda | -$2.7M |
Net Income | -$4.3M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Precipio, Inc. is a leading oncology diagnostics and reagent technology company headquartered in New Haven, Connecticut, dedicated to revolutionizing cancer diagnosis and enhancing patient outcomes. The company leverages cutting-edge technologies to deliver a comprehensive suite of diagnostic products and services tailored for healthcare providers in the U.S. oncology market. With a strong commitment to precision medicine, Precipio stands at the forefront of improving treatment selection and monitoring, positioning itself as an essential contributor to advancement in cancer care.